These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 4976246)
1. Clinical usefulness of iron chelating agents. Waxman HS; Brown EB Prog Hematol; 1969; 6():338-73. PubMed ID: 4976246 [No Abstract] [Full Text] [Related]
2. Iron excretion in thalassemia after the administration of chelating agents. Markum AH; Iskandar W; Keng KL; Odang O Paediatr Indones; 1969; 9(3):89-98. PubMed ID: 4981722 [No Abstract] [Full Text] [Related]
3. [Recent advance in the therapy of metal poisoning with complexing agents]. Aaseth J Tidsskr Nor Laegeforen; 1972 May; 12(13):918-22. PubMed ID: 4624035 [No Abstract] [Full Text] [Related]
4. [The treatment of post-transfusional hemochromatosis with chelating agents]. Delvaux D; Andrien JM; Fillet G Rev Med Liege; 1981 Jun; 36(11):477-80. PubMed ID: 6789438 [No Abstract] [Full Text] [Related]
5. Pathogenesis and management of iron overload in thalassemia. Hershko C Haematologica; 1975 Jun; 60(2):241-8. PubMed ID: 808456 [No Abstract] [Full Text] [Related]
6. [Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease]. Cartei G; Cazzavillan M; Chisesi T; Battista R; Barbui T; Dini E Minerva Med; 1978 Mar; 69(13):811-21. PubMed ID: 643223 [No Abstract] [Full Text] [Related]
8. [Therapy of poisoning with heavy metals]. Hornbostel H; Kaufmann W; Siegenthaler W Dtsch Med Wochenschr; 1975 Apr; 100(17):953-4. PubMed ID: 164336 [No Abstract] [Full Text] [Related]
9. Editorial: Thalassemia major: a problem of iron overload. Stockman JA; Oski FA Ann Intern Med; 1974 Aug; 81(2):262-3. PubMed ID: 4846109 [No Abstract] [Full Text] [Related]
10. [THE TREATMENT OF HEMOCHROMATOSIS]. TUTIN M Prog Med (Paris); 1964 Mar; 92():145-8. PubMed ID: 14147268 [No Abstract] [Full Text] [Related]
11. Ascorbate autoxidation in the presence of iron and copper chelates. Buettner GR Free Radic Res Commun; 1986; 1(6):349-53. PubMed ID: 2851502 [TBL] [Abstract][Full Text] [Related]
12. Ferrioxamine iron in rabbit reticulocyte heme synthesis. Gerlanc MD; Zapolski EJ; Rubin M; Princiotto JV Blood; 1970 Apr; 35(4):493-5. PubMed ID: 5443371 [No Abstract] [Full Text] [Related]
13. [Observations on the internal decontamination of radioelements]. Brenot A; Chiadot P; Rinaldi R Ann Biol Clin (Paris); 1966; 24(10):1223-30. PubMed ID: 5983186 [No Abstract] [Full Text] [Related]
14. Type 3 hemochromatosis and beta-thalassemia trait. Riva A; Mariani R; Bovo G; Pelucchi S; Arosio C; Salvioni A; Vergani A; Piperno A Eur J Haematol; 2004 May; 72(5):370-4. PubMed ID: 15059075 [TBL] [Abstract][Full Text] [Related]
15. Chelation therapy for the treatment of thalassemia. Graziano JH; Cerami A Semin Hematol; 1977 Jan; 14(1):127-34. PubMed ID: 318766 [No Abstract] [Full Text] [Related]
16. [Myocardiopathy caused by iron deposition. Treatment with chelating agents]. Rodríguez Reguero JJ; Iglesias Cubero G; Espolita Santos A; López de la Iglesia JM; Enríquez Martín J; Tomás Mauri J; López-Negrete L Rev Esp Cardiol; 1985; 38(5):356-7. PubMed ID: 4081244 [No Abstract] [Full Text] [Related]